These regulatory documents are aimed to support the interaction with regulatory authorities (EMA or FDA), which helps to smooth the overall process. They are often prepared for pre-submission meetings, request for scientific advice or even protocol assistance. These interactions can influence the clinical development of a product and are therefore critical to companies. From our side, it is essential to deliver documents that are clear and concise, presenting the points of discussion in a direct and accessible manner.